Iron chelators for thalassaemia

Br J Haematol. 1998 Jun;101(3):399-406. doi: 10.1046/j.1365-2141.1998.00726.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Administration, Oral
  • Aza Compounds / therapeutic use
  • Chelating Agents / therapeutic use*
  • Deferiprone
  • Deferoxamine / therapeutic use*
  • Edetic Acid / analogs & derivatives
  • Edetic Acid / therapeutic use
  • Humans
  • Iron / metabolism
  • Iron Chelating Agents / therapeutic use
  • Iron Overload / drug therapy
  • Iron Overload / etiology
  • Long-Term Care
  • Pyridones / therapeutic use
  • Thalassemia / drug therapy*
  • Thalassemia / metabolism

Substances

  • Aza Compounds
  • Chelating Agents
  • Iron Chelating Agents
  • Pyridones
  • Deferiprone
  • N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid
  • Edetic Acid
  • Iron
  • Deferoxamine